During the past decade, Hopital des Cadolles, Neuchatel conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hopital des Cadolles, Neuchatel" are "Breast Cancer" (1 trials) and "Leukemia" (1 trials). Many other conditions were trialed in "Hopital des Cadolles, Neuchatel" in a lesser frequency.

Most popular intervention types in "Hopital des Cadolles, Neuchatel" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (2 trials), "doxorubicin hydrochloride" (2 trials), "CHOP regimen" (1 trials), "cladribine" (1 trials) and "epirubicin hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital des Cadolles, Neuchatel" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hopital des Cadolles, Neuchatel". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hopital des Cadolles, Neuchatel, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hopital des Cadolles, Neuchatel, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".